Mode
Text Size
Log in / Sign up
N/A Completed N=182 Randomized Double-blind Treatment

Integrating Depression Services Into DM Management

Source: ClinicalTrials.gov NCT01098253 ↗
Enrolled (actual)
182
Serious AEs
0.0%
Results posted
Mar 2012
Primary outcomePrimary: Hemoglobin A1C — 60.9; 35.7 Percentage of participants with HbA1c <7

Summary

The goal of this proposal is to integrate depression services into improving adherence for oral hypoglycemic agents so that a single program can assist patients. The investigators hypothesized that patients in the intervention would demonstrate improved adherence to patients' oral hypoglycemic agents and antidepressants as well as improved clinical outcomes.

Outcome Measures

OutcomeResultp-value
PRIMARY
Hemoglobin A1C
60.9; 35.7 —
SECONDARY
Nine Item Patient Health Questionnaire (PHQ-9)
58.7; 30.7 —

Eligibility Criteria

Inclusion Criteria

  • 30 years and older
  • a current diagnosis of Type 2 DM
  • current prescription for an oral hypoglycemic agent
  • current prescription for an antidepressant
  • able to communicate in English
  • willing to give informed consent.

Exclusion Criteria

  • inability to give informed consent
  • significant cognitive impairment at baseline (Mini-Mental State Examination (MMSE) <21)
  • residence in a care facility that provides medications
  • unwillingness or inability to use the Medication Event Monitoring System
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01098253). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search